Editas Medicine, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Editas Medicine, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2023.
  • Editas Medicine, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $4.8M, a 1.5% increase year-over-year.
  • Editas Medicine, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $22.7M, a 14.8% increase year-over-year.
  • Editas Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $19.8M, a 32.4% decline from 2022.
  • Editas Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $29.3M, a 32.5% decline from 2021.
  • Editas Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $43.4M, a 87.4% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $19.8M -$9.5M -32.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $29.3M -$14.1M -32.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $43.4M +$20.2M +87.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-22
2020 $23.2M -$4.09M -15% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
2019 $27.2M +$645K +2.43% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-26
2018 $26.6M +$3.22M +13.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-26
2017 $23.4M +$6.49M +38.5% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 $16.9M +$13.4M +381% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $3.51M +$3.46M +6287% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
2014 $55K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.